Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01316042 · ClinicalTrials.gov registry record · NA
Metformin for the Treatment of Premature Pubarche in Girls
A NA study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01316042 is a NA study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT01316042, a NA study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the safety and efficacy of metformin in lowering serum DHEAS levels in girls with premature pubarche and secondary, to observe changes in hormones associated with pubertal development including gonadotropins, sex steroids, insulin, adipocytokines, and growth factors.
Interventions
- DRUG sugar pill
- DRUG Metformin, glucophage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01316042
The ClinicalTrials.gov registry entry for NCT01316042 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sugar pill is the first listed.
NCT01316042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01316042 about?
NCT01316042 is a clinical study titled "Metformin for the Treatment of Premature Pubarche in Girls". The primary objective of this study is to determine the safety and efficacy of metformin in lowering serum DHEAS levels in girls with premature pubarche and secondary, to observe changes in hormones associated with pubertal development including gonadotropins, sex steroids, insulin, adipocytokines, ...
What is the current status of trial NCT01316042?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2011-05. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01316042?
The interventions under investigation include: sugar pill (DRUG), Metformin, glucophage (DRUG).
Who is sponsoring clinical trial NCT01316042?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.